17.05.2018 - US drugmaker Eli Lilly has agreed to buy Canada’s AurKa Pharma from TVM Capital Life Science, bringing back in-house experimental cancer drug AK-01. The drug, an Aurora kinase A...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
